P. Schoenfeld Asset Management (PSAM)’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$7.99K	–	161
2023 Q1	$7.99K	Hold	100,000	–	–	﹤0.01%	129
2022 Q4	$15.2K	Hold	100,000	–	–	﹤0.01%	160
2022 Q3	$18K	Hold	100,000	–	–	﹤0.01%	247
2022 Q2	$15K	Hold	100,000	–	–	﹤0.01%	310
2022 Q1	$37K	Buy	+100,000	New	+$51.6K	﹤0.01%	365

P. Schoenfeld Asset Management (PSAM)'s ORIAW Position: Q2 2023 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 100,000 shares — an estimated $7.99K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in ORIAW in Q1 2022 and held it in 5 quarters. The position peaked at $37K in Q1 2022. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

P. Schoenfeld Asset Management (PSAM) reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
P. Schoenfeld Asset Management (PSAM) sold 100,000 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $7.99K.
P. Schoenfeld Asset Management (PSAM) first reported a position in Orion Biotech Opportunities Corp. Warrant in Q1 2022 and held it in 5 quarters.
P. Schoenfeld Asset Management (PSAM)'s Orion Biotech Opportunities Corp. Warrant position peaked at $37K in Q1 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2023, filed 11 Aug 2023.